Skip to main content
SpringerLink
Log in
Book cover

Tumeurs endocrines thoraciques et digestives pp 141–146Cite as

Tumeurs endocrines gastro-entéro-pancréatiques (TE GEP): facteurs pronostiques

  • Chapter

Abstrait

Ce chapitre fait le point sur les facteurs pronostiques des tumeurs endocrines gastro-entéro-pancréatiques (TE GEP) non à petites cellules (1, 2). Nous utiliserons le terme de « tumeur endocrine », pour définir des tumeurs bénignes ou malignes. Le terme « carcinoïde » se réfère aux tumeurs bien différenciées. Le terme carcinome est employé pour définir les tumeurs malignes.

This is a preview of subscription content, log in via an institution.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Baudin E (2007) Gastroenteropancreatic endocrine tumors: clinical characterization before therapy. Nat Clin Pract Endocrinol Metabol 3: 228–39

    Article  CAS  Google Scholar 

  2. Plöckinger U, Rindi G, Arnold R et al. (2004) Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. Neuroendocrinol 80: 394–424

    Article  CAS  Google Scholar 

  3. Quaedvlieg PF, Visser O, Lamers CB et al. (2001) Epdidemiology and survival in patients with carcinoid disease in the Netherlands: an epidemiological study with 2391 patients. Ann Oncol 12: 1295–1300

    Article  PubMed  CAS  Google Scholar 

  4. Zar N, Garmo H, Holmberg L et al. (2004) Long-term survival of patients with small intestinal carcinoid tumors.World J Surg 28: 1163–8

    Google Scholar 

  5. Lepage C, Rachet B, Coleman MP (2007) Survival from malignant digestive endocrine tumors in England and Wales: a population-based study. Gastroenterology 132: 899–904

    Article  PubMed  Google Scholar 

  6. Modlin IM, Lye KD, Kidd M (2003) A 5-decade analysis of 13,715 carcinoid tumors. Cancer 97: 934–59

    Article  PubMed  Google Scholar 

  7. Tomassetti P, Campana D, Piscitelli L (2006) Endocrine tumors of the ileum: factors correlated with survival. Neuroendocrinology 83: 380–6

    Article  PubMed  CAS  Google Scholar 

  8. Beasley MB, Thunnissen FB, Brambilla E et al. (2000) Pulmonary atypical carcinoid: predictors of survival in 106 cases. Hum Pathol 31: 1255–65

    Article  PubMed  CAS  Google Scholar 

  9. Johnson LA, Lavin PT, Moertel CG et al. (1986) Carcinoids: the prognostic effect of primary site histologic type variations. J Surg Oncol 33: 81–3

    Article  PubMed  CAS  Google Scholar 

  10. Staren ED, Gould VE, Warren WH et al. (1988) Neuroendocrine carcinomas of the colon and rectum: a clinicopathologic evaluation. Surgery 104: 1080–9

    PubMed  CAS  Google Scholar 

  11. Asamura H, Kameya T, Matsuno Y et al. (2006) Neuroendocrine neoplasms of the lung: a prognostic spectrum. J Clin Oncol 24: 70–6

    Article  PubMed  Google Scholar 

  12. Madeira I, Terris B, Voss M et al. (1998) Prognostic factors in patients with endocrine tumours of the duodenopancreatic area. Gut 43: 422–7

    Article  PubMed  CAS  Google Scholar 

  13. Rindi G, Azzoni C, La Rosa S et al. (1999) ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterology 116: 532–42

    Article  PubMed  CAS  Google Scholar 

  14. Travis WD, Rush W, Flieder DB et al. (1998) Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol 22: 934–44

    Article  PubMed  CAS  Google Scholar 

  15. Lim E, Yap YK, De Stavola BL et al. (2005) The impact of stage and cell type on the prognosis of pulmonary neuroendocrine tumors. J Thorac Cardiovasc Surg 130: 969–72

    Article  PubMed  Google Scholar 

  16. Panzuto F, Nasoni S, Falconi M et al. (2005) Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization. Endocr Relat Cancer 12: 1083–92

    Article  PubMed  Google Scholar 

  17. Faggiano A, Sabourin JC, Ducreux M et al. (2007) Pulmonary and extrapulmonary poorly differentiated large cell neuroendocrine carcinomas: diagnostic and prognostic features. Cancer 110: 265–74

    Article  PubMed  CAS  Google Scholar 

  18. Granberg D, Wilander E, Oberg K et al. (2000) Prognostic markers in patients with typical bronchial carcinoid tumors. J Clin Endocrinol Metab 85: 3425–3430

    Article  PubMed  CAS  Google Scholar 

  19. Cardillo G, Dstat FS, Di Martino M et al. (2004) Bronchial carcinoid tumors: nodal status and long-term survival after resection. Ann Thor Surg 77: 1781–5

    Article  Google Scholar 

  20. Garcia-Yuste M, Matilla JM, Cueto A et al. (2007) Typical and atypical carcinoid tumours: analysis of the experience of the Spanish Multi-centric Study of Neuroendocrine Tumours of the Lung. Eur J Cardiothorac Surg 31: 192–7

    Article  PubMed  Google Scholar 

  21. Hellman P, Lundstrom T, Ohrvall U et al. (2002) Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases. World J Surg 26: 991–7

    Article  PubMed  Google Scholar 

  22. Thomas CF, Tazelaar HD, Jett JR (2001) Typical and atypical pulmonary carcinoids: outcome in patients presenting with regional lymph node involvement. Chest 119: 1143–50

    Article  PubMed  Google Scholar 

  23. Mezzetti M, Raveglia F, Panigalli T et al. (2003) Assessment of outcomes in typical and atypical carcinoids according to latest WHO classification. Ann Thorac Surg 76: 1838–42

    Article  PubMed  Google Scholar 

  24. Pelosi G, Bresaola E, Bogina G et al. (1996) Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections is an independent predictor for malignancy: a comparative study with proliferating-cell nuclear antigen and progesterone receptor protein immunostaining, mitotic index, and other clinicopathologic variables. Hum Pathol 27: 1124–34

    Article  PubMed  CAS  Google Scholar 

  25. Rigaud G, Missiaglia E, Moore PS et al. (2001) High resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications. Cancer Res 61: 285–92

    PubMed  CAS  Google Scholar 

  26. Hochwald SN, Zee S, Conlon KC et al. (2002) Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. J Clin Oncol 20: 2633–42

    Article  PubMed  Google Scholar 

  27. Onaitis MW, Kirshbom PM, Hayward TZ et al. (2000) Gastrointestinal carcinoids: characterization by site of origin and hormone production. Ann Surg 232: 549–56

    Article  PubMed  CAS  Google Scholar 

  28. Clancy TE, Sengupta TP, Paulus J et al. (2006) Alkaline phosphatase predicts survival in patients with metastatic neuroendocrine tumors. Dig Dis Sci 51: 877–84

    Article  PubMed  CAS  Google Scholar 

  29. Chamberlain RS, Canes D, Brown KT et al. (2000) Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg 190: 432–45

    Article  PubMed  CAS  Google Scholar 

  30. Yu F, Venzon DJ, Serrano J et al. (1999) Prospective study of the clinical course, prognostic factors, cause of death, and survival in patients with long-standing Zollinger-Ellison syndrome. J Clin Oncol 17: 615–30

    PubMed  CAS  Google Scholar 

  31. Janson ET, Holmberg L, Stridsberg M et al. (1997) Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center. Ann Oncol 8: 685–90

    Article  PubMed  CAS  Google Scholar 

  32. Chaudry A, Oberg K, Wilander E (1992) A study of biological behavior based on the expression of a proliferating antigen in neuroendocrine tumors of the digestive system. Tum Biol 13: 27–35

    Google Scholar 

  33. Pellikka PA, Tajik AJ, Khandheria BK et al. (1993) Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients. Circulation 87: 1188–96

    PubMed  CAS  Google Scholar 

  34. Sutcliff VE, Doppman JL, Gibril F et al. (1997) Growth of newly diagnosed, untreated metastatic gastrinomas and predictors of growth patterns. J Clin Oncol 15: 2420–31

    Google Scholar 

  35. Arnold R, Frank M (1996) Control of growth in neuroendocrine gastro-enteropancreatic tumours. Digestion 57: S69–S71 (suppl 1)

    Article  Google Scholar 

  36. Pape UF, Bohmig M, Berndt U et al. (2004) Survival and clinical outcome of patients with neuroendocrine tumors of the gastroenteropancreatic tract in a german referral center. Ann N Y Acad Sci 1014: 222–33

    Article  PubMed  Google Scholar 

  37. Weber HC, Venzon DJ, Lin JT et al. (1995) Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. Gastroenterology 108: 1637–49

    Article  PubMed  CAS  Google Scholar 

  38. Turner GB, Johnston BT, McCance DR et al. (2006) Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours. Gut 55: 1586–91

    Article  PubMed  CAS  Google Scholar 

  39. Greenberg RS, Baumgarten DA, Clark WS et al. (1987) Prognostic factors for gastrointestinal and bronchopulmonary carcinoid tumors. Cancer 60: 2476–83

    Article  PubMed  CAS  Google Scholar 

  40. Soreide JA, van Heerden JA, Thompson GB et al. (2000) Gastrointestinal carcinoid tumors: long-term prognosis for surgically treated patients. World J Surg 24: 1431–6

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Médecine nucléaire et oncologie endocrinienne, Institut Gustave-Roussy, 39, rue Camille-Desmoulins, 94805, Villejuif Cedex

    É. Baudin

  2. Unité de gastro-entérologie, Département de médecine, Institut Gustave-Roussy, 39, rue Camille-Desmoulins, 94805, Villejuif Cedex

    D. Malka

  3. Département de médecine, Institut Gustave-Roussy, 39, rue Camille-Desmoulins, 94805, Villejuif Cedex

    J. Guigay

  4. Service de gastro-entérologie, Département de médecine, Institut Gustave-Roussy, 39, rue Camille-Desmoulins, Villejuif Cedex

    M. Ducreux

  5. département de cancérologie, Hôpital universitaire Paul-Brousse, Rue P.Vaillant-Couturier, 94805, Villejuif Cedex

    M. Ducreux

Authors
  1. É. Baudin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Malka
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Guigay
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Ducreux
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag France, Paris

About this chapter

Cite this chapter

Baudin, É., Malka, D., Guigay, J., Ducreux, M. (2008). Tumeurs endocrines gastro-entéro-pancréatiques (TE GEP): facteurs pronostiques. In: Tumeurs endocrines thoraciques et digestives. Springer, Paris. https://doi.org/10.1007/978-2-287-35574-5_12

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-35574-5_12

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-35573-8

  • Online ISBN: 978-2-287-35574-5

Publish with us

Policies and ethics

Search

Navigation